| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO & President
1 company
Menderes Akdag last filed a Form 4 in January 2021, as CEO & President at PETS. From January 2015 to January 2021, the filings on record show 0 open-market purchases and 24 sales. Menderes Akdag's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 337,800 shares of PETS. The PETS filings lean toward selling, a net 438,000 shares.
Shares as reported in the last Form 4 for each company; the most recent is from January 2021. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 13, 2015 | PETS Petmed Express Inc | CEO & President | Sell | 7,499 | $16.75 | $125,608.25 | -1.4% | |
| Apr 8, 2015 | PETS Petmed Express Inc | CEO & President | Sell | 2,501 | $16.75 | $41,891.75 | -0.5% | |
| Mar 30, 2015 | PETS Petmed Express Inc | CEO & President | Sell | 10,000 | $16.50 | $165,000.00 | -1.8% | |
| Jan 21, 2015 | PETS Petmed Express Inc | CEO & President | Sell | 60,000 | $15.63 | $937,800.00 | -9.7% |